Series A momentum BrainCheck recently closed a $13M Series A led by Next Coast Ventures with participation from S3 Ventures and UPMC Enterprises, signaling strong investor confidence and room for scaled partnerships with large healthcare networks.

Healthcare enterprise fit The platform integrates into clinical workflows and EHR systems, appealing to health systems and providers seeking digital cognitive assessment and care planning tools to enhance proactive screening and personalized care.

Executive leadership shift A change in revenue leadership with the departure of the Chief Revenue Officer suggests a potential period of strategic alignment and renewed go-to-market initiatives, presenting an opportune moment to engage on partnerships and channel opportunities.

Awards and credibility Industry recognition such as the MedTech Breakthrough award for Care Management Innovation enhances credibility with potential customers and payers, supporting outreach to health systems evaluating innovative cognitive care solutions.

Growth and scale signals Revenue is in the tens of millions with a headcount of 51-200, indicating a growth-ready but still relationship-driven sales approach; target large health networks, integrated delivery networks, and enterprise insurers for expansion of adoption and integration.